HomeProductsBuilding BlocksHeterocyclic ScaffoldsPyrrolesVV116
Chemical structure of CAS 2647442-33-7

VV116

CAS No.2647442-33-7
MDL No.N/A
MFC24H31N5O7
MW502.50
InChI KeyRVSSLHFYCSUAHY-QXMJNOOVSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.2647442-33-7
Product NameVV116

Associated Conditions

viral disease
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Lessons learnt from broad-spectrum coronavirus antiviral drug discovery.

Expert opinion on drug discovery • Vol. 19, Issue 9 • 2024
PMID: 39078037PMC: PMC11390334DOI: 10.1080/17460441.2024.2385598

Deuremidevir and Simnotrelvir-Ritonavir for the Treatment of COVID-19.

ACS pharmacology & translational science • Vol. 6, Issue 9 • 2023
PMID: 37705591PMC: PMC10496140DOI: 10.1021/acsptsci.3c00134

Safety, tolerability, and pharmacokinetics of VV116, an oral nucleoside analog against SARS-CoV-2, in Chinese healthy subjects.

Acta pharmacologica Sinica • Vol. 43, Issue 12 • 2022
PMID: 35296780PMC: PMC8924727DOI: 10.1038/s41401-022-00895-6

Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2.

Cell research • Vol. 31, Issue 11 • 2021
PMID: 34584244PMC: PMC8477624DOI: 10.1038/s41422-021-00570-1

Documentation

Similar Products